Repligen reported $1.81B in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agilent A:US $ 5091M 31M
Align Technology ALGN:US $ 3599.08M 67.77M
Bio Techne TECH:US $ 1701.01M 13.36M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Bruker BRKR:US $ 984.4M 32.6M
Catalent CTLT:US $ 4795M 163M
Charles River Laboratories CRL:US $ 2647.71M 37.52M
Danaher DHR:US $ 46594M 238M
Exact Sciences EXAS:US $ 3209.35M 48.86M
General Electric GE:US $ 34649M 4356M
Henry Schein HSIC:US $ 3594M 2M
Illumina ILMN:US $ 10444M 451M
IQVIA Holdings Inc IQV:US $ 5.35B 567M
Mettler Toledo International MTD:US 7.26M 77.31M
Myriad Genetics MYGN:US $ 947.4M 2.7M
Nanostring Technologies NSTG:US $ 112.66M 32.64M
Orasure Technologies OSUR:US $ 344.19M 20.69M
Patterson Companies PDCO:US $ 1025.89M 15.79M
Peregrine Pharmaceuticals PPHM:US $ 179M 4.47M
Perkinelmer PKI:US $ 7167.16M 19.19M
Repligen RGEN:US $ 1805.36M 38.96M
Thermo Fisher Scientific TMO:US $ 42354M 1398M
Waters WAT:US $ 392.12M 17.19M
West Pharmaceutical Services WST:US $ 2424.4M 98.2M